Pandemic Influenza Vaccine Market Report

Global Pandemic Influenza Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：231
  • REPORT CODE：GMM841325
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pandemic Influenza Vaccine market report explains the definition, types, applications, major countries, and major players of the Pandemic Influenza Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Lupin

    • Sementis

    • Valneva

    • Solvay and Serum Institute of India Pvt Ltd

    • GlaxoSmithKline

    • Novartis

    • AstraZeneca

    • Sanofi

    • Chiron Panacea

    By Type:

    • Influenza A (H1N1) Vaccines

    • Other

    By End-User:

    • Adult

    • Paediatric

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pandemic Influenza Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pandemic Influenza Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Pandemic Influenza Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pandemic Influenza Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pandemic Influenza Vaccine Market- Recent Developments

    • 6.1 Pandemic Influenza Vaccine Market News and Developments

    • 6.2 Pandemic Influenza Vaccine Market Deals Landscape

    7 Pandemic Influenza Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Pandemic Influenza Vaccine Key Raw Materials

    • 7.2 Pandemic Influenza Vaccine Price Trend of Key Raw Materials

    • 7.3 Pandemic Influenza Vaccine Key Suppliers of Raw Materials

    • 7.4 Pandemic Influenza Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Pandemic Influenza Vaccine Cost Structure Analysis

      • 7.5.1 Pandemic Influenza Vaccine Raw Materials Analysis

      • 7.5.2 Pandemic Influenza Vaccine Labor Cost Analysis

      • 7.5.3 Pandemic Influenza Vaccine Manufacturing Expenses Analysis

    8 Global Pandemic Influenza Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pandemic Influenza Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pandemic Influenza Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pandemic Influenza Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pandemic Influenza Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Influenza A (H1N1) Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pandemic Influenza Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Paediatric Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pandemic Influenza Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.2 UK Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.5 France Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.3 India Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Pandemic Influenza Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pandemic Influenza Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Pandemic Influenza Vaccine Consumption (2017-2022)

    11 Global Pandemic Influenza Vaccine Competitive Analysis

    • 11.1 Lupin

      • 11.1.1 Lupin Company Details

      • 11.1.2 Lupin Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Lupin Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.1.4 Lupin Pandemic Influenza Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sementis

      • 11.2.1 Sementis Company Details

      • 11.2.2 Sementis Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sementis Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.2.4 Sementis Pandemic Influenza Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Valneva

      • 11.3.1 Valneva Company Details

      • 11.3.2 Valneva Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Valneva Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.3.4 Valneva Pandemic Influenza Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Solvay and Serum Institute of India Pvt Ltd

      • 11.4.1 Solvay and Serum Institute of India Pvt Ltd Company Details

      • 11.4.2 Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.4.4 Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 GlaxoSmithKline

      • 11.5.1 GlaxoSmithKline Company Details

      • 11.5.2 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 GlaxoSmithKline Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.5.4 GlaxoSmithKline Pandemic Influenza Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.6.4 Novartis Pandemic Influenza Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 AstraZeneca

      • 11.7.1 AstraZeneca Company Details

      • 11.7.2 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 AstraZeneca Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.7.4 AstraZeneca Pandemic Influenza Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Sanofi

      • 11.8.1 Sanofi Company Details

      • 11.8.2 Sanofi Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Sanofi Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.8.4 Sanofi Pandemic Influenza Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Chiron Panacea

      • 11.9.1 Chiron Panacea Company Details

      • 11.9.2 Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Chiron Panacea Pandemic Influenza Vaccine Main Business and Markets Served

      • 11.9.4 Chiron Panacea Pandemic Influenza Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Pandemic Influenza Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pandemic Influenza Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Influenza A (H1N1) Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pandemic Influenza Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Paediatric Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pandemic Influenza Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pandemic Influenza Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pandemic Influenza Vaccine

    • Figure of Pandemic Influenza Vaccine Picture

    • Table Global Pandemic Influenza Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pandemic Influenza Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Influenza A (H1N1) Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Paediatric Consumption and Growth Rate (2017-2022)

    • Figure Global Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Table North America Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure United States Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Germany Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure China Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pandemic Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Australia Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pandemic Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Lupin Company Details

    • Table Lupin Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Lupin Pandemic Influenza Vaccine Product Portfolio

    • Table Sementis Company Details

    • Table Sementis Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sementis Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Sementis Pandemic Influenza Vaccine Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Valneva Pandemic Influenza Vaccine Product Portfolio

    • Table Solvay and Serum Institute of India Pvt Ltd Company Details

    • Table Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Solvay and Serum Institute of India Pvt Ltd Pandemic Influenza Vaccine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Pandemic Influenza Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Pandemic Influenza Vaccine Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Novartis Pandemic Influenza Vaccine Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Pandemic Influenza Vaccine Main Business and Markets Served

    • Table AstraZeneca Pandemic Influenza Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Sanofi Pandemic Influenza Vaccine Product Portfolio

    • Table Chiron Panacea Company Details

    • Table Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiron Panacea Pandemic Influenza Vaccine Main Business and Markets Served

    • Table Chiron Panacea Pandemic Influenza Vaccine Product Portfolio

    • Figure Global Influenza A (H1N1) Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Paediatric Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pandemic Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pandemic Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US